The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
94349286 9434928 6 F 2008 20160623 20130801 20160706 EXP BR-ROCHE-1255550 ROCHE 0.00 F Y 62.00000 KG 20160706 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
94349286 9434928 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous DOSE: 75/100 MG, 12.5 AMPOULES 103976 375 MG
94349286 9434928 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK 103976
94349286 9434928 3 SS FORASEQ BUDESONIDEFORMOTEROL FUMARATE 1 Respiratory (inhalation) 400/12 MG 0 1 DF CAPSULE BID
94349286 9434928 4 C ENALAPRIL ENALAPRIL 1 Oral 1 DF, QD 0 20 MG TABLET QD
94349286 9434928 5 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 1 DF, QD 0 25 UG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
94349286 9434928 1 Asthma
94349286 9434928 3 Asthma
94349286 9434928 4 Blood pressure abnormal
94349286 9434928 5 Hypertension

Outcome of event

Event ID CASEID OUTC COD
94349286 9434928 HO
94349286 9434928 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
94349286 9434928 Asthma
94349286 9434928 Back pain
94349286 9434928 Chronic sinusitis
94349286 9434928 Condition aggravated
94349286 9434928 Dyspnoea
94349286 9434928 Erythema
94349286 9434928 Fatigue
94349286 9434928 Hypertension
94349286 9434928 Hypothyroidism
94349286 9434928 Malaise
94349286 9434928 Nasal dryness
94349286 9434928 Nasal inflammation
94349286 9434928 Nasal obstruction
94349286 9434928 Pneumonitis
94349286 9434928 Syncope
94349286 9434928 Visual impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
94349286 9434928 1 20081007 0
94349286 9434928 2 20130715 0
94349286 9434928 3 2006 0